170 related articles for article (PubMed ID: 15780446)
1. Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.
Tatalick LM; Gerard CJ; Takeya R; Price DN; Thorne BA; Wyatt LM; Anklesaria P
Vaccine; 2005 Apr; 23(20):2628-38. PubMed ID: 15780446
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenicity assessments of Per.C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line.
Ledwith BJ; Lanning CL; Gumprecht LA; Anderson CA; Coleman JB; Gatto NT; Balasubramanian G; Farris GM; Kemp RK; Harper LB; Barnum AB; Pacchione SJ; Mauer KL; Troilo PF; Brown ER; Wolf JJ; Lebronl JA; Lewis JA; Nichols WW
Dev Biol (Basel); 2006; 123():251-63; discussion 265-6. PubMed ID: 16566451
[TBL] [Abstract][Full Text] [Related]
3. Optimised helper virus-free production of high-quality adeno-associated virus vectors.
Drittanti L; Jenny C; Poulard K; Samba A; Manceau P; Soria N; Vincent N; Danos O; Vega M
J Gene Med; 2001; 3(1):59-71. PubMed ID: 11269337
[TBL] [Abstract][Full Text] [Related]
4. Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India.
Mehendale S; Sahay S; Thakar M; Sahasrabuddhe S; Kakade M; Shete A; Shrotri A; Spentzou A; Tarragona T; Stevens G; Kochhar S; Excler JL; Fast P; Paranjape R
Indian J Med Res; 2010 Aug; 132():168-75. PubMed ID: 20716817
[TBL] [Abstract][Full Text] [Related]
5. Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.
Coupar BE; Purcell DF; Thomson SA; Ramshaw IA; Kent SJ; Boyle DB
Vaccine; 2006 Feb; 24(9):1378-88. PubMed ID: 16257479
[TBL] [Abstract][Full Text] [Related]
6. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
7. Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine production.
Liu J; Mani S; Schwartz R; Richman L; Tabor DE
Vaccine; 2010 Feb; 28(5):1285-93. PubMed ID: 19944150
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5.
Lochrie MA; Tatsuno GP; Arbetman AE; Jones K; Pater C; Smith PH; McDonnell JW; Zhou SZ; Kachi S; Kachi M; Campochiaro PA; Pierce GF; Colosi P
Virology; 2006 Sep; 353(1):68-82. PubMed ID: 16806384
[TBL] [Abstract][Full Text] [Related]
9. Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines.
Lewis JA; Brown EL; Duncan PA
Dev Biol (Basel); 2006; 123():165-76; discussion 183-97. PubMed ID: 16566444
[TBL] [Abstract][Full Text] [Related]
10. Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system.
Ye GJ; Scotti MM; Liu J; Wang L; Knop DR; Veres G
Gene Ther; 2011 Feb; 18(2):135-44. PubMed ID: 20668485
[TBL] [Abstract][Full Text] [Related]
11. Proposed algorithm to investigate latent and occult viruses in vaccine cell substrates by chemical induction.
Khan AS; Ma W; Ma Y; Kumar A; Williams DK; Muller J; Ma H; Galvin TA
Biologicals; 2009 Jun; 37(3):196-201. PubMed ID: 19299169
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID: 18328408
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
